Abstract

Perforin-2 (MPEG1) is a pore-forming, antibacterial protein with broad-spectrum activity. Perforin-2 is expressed constitutively in phagocytes and inducibly in parenchymal, tissue-forming cells. In vitro, Perforin-2 prevents the intracellular replication and proliferation of bacterial pathogens in these cells. Perforin-2 knockout mice are unable to control the systemic dissemination of methicillin-resistant Staphylococcus aureus (MRSA) or Salmonella typhimurium and perish shortly after epicutaneous or orogastric infection respectively. In contrast, Perforin-2-sufficient littermates clear the infection. Perforin-2 is a transmembrane protein of cytosolic vesicles -derived from multiple organelles- that translocate to and fuse with bacterium containing vesicles. Subsequently, Perforin-2 polymerizes and forms large clusters of 100Å pores in the bacterial surface with Perforin-2 cleavage products present in bacteria. Perforin-2 is also required for the bactericidal activity of reactive oxygen and nitrogen species and hydrolytic enzymes. Perforin-2 constitutes a novel and apparently essential bactericidal effector molecule of the innate immune system.

Article and author information

Author details

  1. Ryan M McCormack

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    Ryan M McCormack, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..
  2. Lesley R de Armas

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    Lesley R de Armas, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..
  3. Motoaki Shiratsuchi

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  4. Desiree G Fiorentino

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  5. Melissa L Olsson

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  6. Mathias G Lichtenheld

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  7. Alejo Morales

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  8. Kirill Lyapichev

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    Kirill Lyapichev, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..
  9. Louis E Gonzalez

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  10. Natasa Strbo

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  11. Neelima Sukumar

    Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  12. Olivera Stojadinovic

    Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  13. Gregory V Plano

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  14. George P Munson

    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  15. Marjana Tomic-Canic

    Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  16. Robert S Kirsner

    Wound Healing and Regenerative Medicine Research Program, Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, United States
    Competing interests
    No competing interests declared.
  17. David G Russell

    Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  18. Eckhard R Podack

    Microbiology and Immunology, U. Miami, School of Medicine, Miami, United States
    For correspondence
    epodack@miami.edu
    Competing interests
    Eckhard R Podack, This author is an inventor of patents used in the study and stand to gain royalties from future commercialization..

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#13-233 and #12-259) of the University of Miami Miller School of Medicine.

Copyright

© 2015, McCormack et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,849
    views
  • 906
    downloads
  • 72
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ryan M McCormack
  2. Lesley R de Armas
  3. Motoaki Shiratsuchi
  4. Desiree G Fiorentino
  5. Melissa L Olsson
  6. Mathias G Lichtenheld
  7. Alejo Morales
  8. Kirill Lyapichev
  9. Louis E Gonzalez
  10. Natasa Strbo
  11. Neelima Sukumar
  12. Olivera Stojadinovic
  13. Gregory V Plano
  14. George P Munson
  15. Marjana Tomic-Canic
  16. Robert S Kirsner
  17. David G Russell
  18. Eckhard R Podack
(2015)
Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria
eLife 4:e06508.
https://doi.org/10.7554/eLife.06508

Share this article

https://doi.org/10.7554/eLife.06508

Further reading

    1. Immunology and Inflammation
    Alexander J Knights, Easton C Farrell ... Tristan Maerz
    Research Article

    Synovium is home to immune and stromal cell types that orchestrate inflammation following a joint injury; in particular, macrophages are central protagonists in this process. We sought to define the cellular and temporal dynamics of the synovial immune niche in a mouse model of post-traumatic osteoarthritis (PTOA), and to identify stromal-immune crosstalk mechanisms that coordinate macrophage function and phenotype. We induced PTOA in mice using a non-invasive tibial compression model of anterior cruciate ligament rupture (ACLR). Single-cell RNA-sequencing and flow cytometry were used to assess immune cell populations in healthy (Sham) and injured (7 and 28 days post-ACLR) synovium. Characterization of synovial macrophage polarization states was performed, alongside computational modeling of macrophage differentiation, as well as implicated transcriptional regulators and stromal-immune communication axes. Immune cell types are broadly represented in healthy synovium, but experience drastic expansion and speciation in PTOA, most notably in the macrophage portion. We identified several polarization states of macrophages in synovium following joint injury, underpinned by distinct transcriptomic signatures, and regulated in part by stromal-derived macrophage colony-stimulating factor signaling. The transcription factors Pu.1, Cebpα, Cebpβ, and Jun were predicted to control differentiation of systemically derived monocytes into pro-inflammatory synovial macrophages. In summary, we defined different synovial macrophage subpopulations present in healthy and injured mouse synovium. Nuanced characterization of the distinct functions, origins, and disease kinetics of macrophage subtypes in PTOA will be critical for targeting these highly versatile cells for therapeutic purposes.

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Benita Martin-Castaño, Patricia Diez-Echave ... Julio Galvez
    Research Article

    Coronavirus disease 2019 (COVID-19) is a respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that displays great variability in clinical phenotype. Many factors have been described to be correlated with its severity, and microbiota could play a key role in the infection, progression, and outcome of the disease. SARS-CoV-2 infection has been associated with nasopharyngeal and gut dysbiosis and higher abundance of opportunistic pathogens. To identify new prognostic markers for the disease, a multicentre prospective observational cohort study was carried out in COVID-19 patients divided into three cohorts based on symptomatology: mild (n = 24), moderate (n = 51), and severe/critical (n = 31). Faecal and nasopharyngeal samples were taken, and the microbiota was analysed. Linear discriminant analysis identified Mycoplasma salivarium, Prevotella dentalis, and Haemophilus parainfluenzae as biomarkers of severe COVID-19 in nasopharyngeal microbiota, while Prevotella bivia and Prevotella timonensis were defined in faecal microbiota. Additionally, a connection between faecal and nasopharyngeal microbiota was identified, with a significant ratio between P. timonensis (faeces) and P. dentalis and M. salivarium (nasopharyngeal) abundances found in critically ill patients. This ratio could serve as a novel prognostic tool for identifying severe COVID-19 cases.